4//SEC Filing
Shah Prem S 4
Accession 0001127602-24-005070
CIK 0000064803other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:12 PM ET
Size
18.4 KB
Accession
0001127602-24-005070
Insider Transaction Report
Form 4
Shah Prem S
EVP and Group President
Transactions
- Award
Common Stock
2024-02-12+13,313→ 69,237.762 total
Holdings
- 29,649
Common Stock (Restricted)
- 4,788.942
ESOP Common Stock
- 3,350.356
Stock Unit (deferred)
- 33,754.62
Phantom Stock Credits
Exercise: $1.00→ Common Stock (33,754.62 underlying) - 846
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (846 underlying) - 9,469
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (9,469 underlying) - 28,596
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (28,596 underlying) - 26,580
Stock Option
Exercise: $75.24From: 2021-08-31Exp: 2028-08-31→ Common Stock (26,580 underlying) - 28,723
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (28,723 underlying) - 41,580
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (41,580 underlying) - 89,073
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (89,073 underlying)
Footnotes (11)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
- [F10]Option became exercisable in four equal installments, commencing 4/1/2023.
- [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
- [F2]Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
- [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F5]Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
- [F6]Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
- [F7]Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
- [F8]Option became exercisable in three equal installments, commencing on 8/31/2021.
- [F9]Option became exercisable in three equal installments commencing 04/01/2022.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001900910
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:12 PM ET
- Size
- 18.4 KB